621 related articles for article (PubMed ID: 6980743)
21. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
O'Sullivan MM; Walker DM; Williams BD
Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
[TBL] [Abstract][Full Text] [Related]
22. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
23. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
26. Pemphigus foliaceus in a patient with rheumatoid arthritis and Sjögren's syndrome. A case report.
Falk ES
Dermatologica; 1979; 158(5):348-54. PubMed ID: 374144
[TBL] [Abstract][Full Text] [Related]
27. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
28. [Comparative studies in patients with seropositive and seronegative chronic polyarthritis using the solid-phase ELISA test for the determination of rheumatoid factors of classes IgM, IgG and IgA].
Zlabinger GJ; Bröll H
Z Rheumatol; 1988; 47(2):107-12. PubMed ID: 3388991
[TBL] [Abstract][Full Text] [Related]
29. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
30. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
31. IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes.
Carson DA; Bayer AS; Eisenberg RA; Lawrance S; Theofilopoulos A
Clin Exp Immunol; 1978 Jan; 31(1):100-3. PubMed ID: 639341
[TBL] [Abstract][Full Text] [Related]
32. IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome.
Dunne JV; Carson DA; Spiegelberg HL; Alspaugh MA; Vaughan JH
Ann Rheum Dis; 1979 Apr; 38(2):161-5. PubMed ID: 443882
[TBL] [Abstract][Full Text] [Related]
33. Characterization of intraepidermal IgG deposits in patients with primary Sjögren's syndrome.
Oxholm P; Thomsen BS; Graem N; Oxholm A; Prause JU; Manthorpe R; Mansa B
Scand J Rheumatol Suppl; 1986; 61():181-4. PubMed ID: 3296146
[TBL] [Abstract][Full Text] [Related]
34. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of Sjögren's syndrome in rheumatoid arthritis.
He J; Ding Y; Feng M; Guo J; Sun X; Zhao J; Yu D; Li Z
Rheumatology (Oxford); 2013 Jun; 52(6):1084-9. PubMed ID: 23382356
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
37. High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.
Moutsopoulos HM; Steinberg AD; Fauci AS; Lane HC; Papadopoulos NM
J Immunol; 1983 Jun; 130(6):2663-5. PubMed ID: 6406594
[TBL] [Abstract][Full Text] [Related]
38. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
39. IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes.
Herrmann D; Jäger L; Hein G; Henzgen M; Schlenvoigt G
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):302-7. PubMed ID: 1669588
[TBL] [Abstract][Full Text] [Related]
40. [Immuno-diagnostic findings in "secondary" Sjögren syndrome in chronic polyarthritis].
Grevers G; Späth M; Krüger K; Schattenkirchner M
Laryngorhinootologie; 1990 Nov; 69(11):605-7. PubMed ID: 2264912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
